First large-scale PheWAS study using EMRs provides systematic method to discover new disease association

November 25, 2013

Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology.

Traditional genetic studies start with one phenotype and look at one or many genotypes, PheWAS does the inverse by looking at many diseases for one genetic variant or genotype.

"This study broadly shows that we can take decades of off-the-shelf data, link them to DNA, and quickly validate known associations across hundreds of previous studies," said lead author Josh Denny, M.D., M.S., Vanderbilt Associate Professor of Biomedical Informatics and Medicine. "And, at the same time, we can discover many new associations.

"A third important finding is that our method does not select any particular disease - it is searches simultaneously for more than a thousand diseases that bring one to the doctor. By doing this, we were able to show some genes that are associated several diseases or traits, while others are not," he added.

Researchers used genotype data from 13,835 individuals of European descent, exhibiting 1,358 diseases collectively. The team then ran PheWAS on 3,144 single-nucleotide polymorphisms (SNP's), checking each SNP's association with each of the 1,358 disease phenotypes.

As a result, study authors reported 63 previously unknown SNP-disease associations, the strongest of which related to .

The video will load shortly.
Vanderbilt University Medical Center researchers and co-authors from four other US institutions from the Electronic Medical Records and Genomics Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study, released today in Nature Biotechnology. Credit: Video courtesy of Vanderbilt University

"The key result is that the method works," Denny said. "This is a robust test of PheWAS across all domains of disease, showing that you can see all types of phenotypes in the electronic medical record—cancers, diabetes, heart diseases, brain diseases, etc.—and replicate what's known about their associations with various SNPs."

An online PheWAS catalog spawned by the study may help investigators understand the influence of many common genetic variants on human conditions.

"If you think about the way genetic research has been done for the last 50 years or more, a lot of it was done through carefully planned clinical trials or observational cohorts," Denny said. "This certainly does not supplant those in any way but provides a cost efficient, systematic method to look at many different diseases over time in a way that you really can't do easily with an observational cohort."

Denny said PheWAS would be unworkable without the eMERGE Network, which has now expanded to nine sites with DNA samples from about 51,000 individuals linked to . Vanderbilt is the coordinating center for eMERGE. The eMERGE Network is funded by the National Human Genome Research Institute.

"PheWAS opens up important avenues in understanding why certain diseases can present differently in different people, or how drugs might produce unpredicted effects in some patients," said senior author Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, and principal investigator for the Vanderbilt eMERGE site.

Explore further: Study finds gene network associated with alcohol dependence

Related Stories

Study finds gene network associated with alcohol dependence

November 21, 2013
There is good evidence from studies of families and twins that genetics plays an important role in the development of alcoholism. However, hundreds of genes likely are involved in this complex disorder, with each variant ...

Researchers identify genetic variants predicting aggressive prostate cancers

June 19, 2013
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic ...

Electronic medical records speed genetic health studies

April 20, 2011
Recruiting thousands of patients to collect health data for genetic clues to disease is expensive and time consuming. But that arduous process of collecting data for genetic studies could be faster and cheaper by instead ...

A genetic map for complex diseases

September 26, 2013
Although heavily studied, the specific genetic causes of "complex diseases," a category of disorders which includes autism, diabetes and heart disease, are largely unknown due to byzantine genetic and environmental interactions.

New approach for efficient analysis of emerging genetic data

September 6, 2012
(Medical Xpress)—With the ability to sequence human genes comes an onslaught of raw material about the genetic characteristics that distinguish us, and wading through these reserves of data poses a major challenge for life ...

Recommended for you

Forgotten strands of DNA initiate the development of immune cells

September 21, 2017
Intricate human physiological features such as the immune system require exquisite formation and timing to develop properly. Genetic elements must be activated at just the right moment, across vast distances of genomic space.

Genome editing reveals role of gene important for human embryo development

September 20, 2017
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development. This is the first time that genome editing has been used to study gene function in human ...

A piece of the puzzle: Eight autism-related mutations in one gene

September 19, 2017
Scientists have identified a hotspot for autism-related mutations in a single gene.

Scientists identify key regulator of male fertility

September 19, 2017
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.

New assay leads to step toward gene therapy for deaf patients

September 18, 2017
Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

A new approach to high insulin levels

September 18, 2017
Diabetes is characterised by a deficiency of insulin. Its opposite is a condition called congenital hyperinsulinism—patients produce the hormone too frequently and in excessive quantities, even if they haven't eaten any ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.